IHS Chemical Week

World News and Views :: Top of the News

Merck Serono appoints head of R&D

7:04 AM MDT | July 15, 2014 | Natasha Alperowicz

Merck Serono, the biopharmaceutical division of Merck KGaA, has announced the appointment of Luciano Rossetti as executive v.p. and head/R&D as of 21 July.  In his most recent role, Rossetti acted as senior v.p./late-stage development at Merck Sharp & Dohme (MSD).  He was responsible for the clinical development from phase two to phase five across all therapeutic areas. At MSD, he played a key role in shaping and implementing the development strategy of several potential breakthrough compounds, such as anti PD-1. He also restructured the...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa